Advanced Drug Delivery Systems Global Market Report 2026
상품코드:1939196
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
첨단 약물전달 시스템 시장 규모는 최근 현저한 성장을 보이고 있습니다. 2025년 2,855억 9,000만 달러에서 2026년에는 3,101억 5,000만 달러로, CAGR 8.6%로 확대할 전망입니다. 지난 수년간의 성장은 제약 분야의 연구개발 활동 확대, 만성질환 유병률 증가, 제제 과학의 발전, 주사제 치료의 성장, 치료 효과에 대한 관심 증가 등이 주요 요인으로 꼽힙니다.
첨단 약물전달 시스템 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 4,335억 6,000만 달러에 달하며, CAGR은 8.7%에 달할 전망입니다. 예측 기간 중 성장 요인으로는 맞춤형 의료에 대한 수요 증가, 생물제제의 채택 확대, 나노테크놀러지 기반 치료의 발전, 약물 부작용 감소에 대한 집중 강화, 첨단 의약품 전달 플랫폼에 대한 투자 증가 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 표적 약물전달 기술 채택 확대, 나노 캐리어 기반 제제 사용 증가, 서방형 시스템에 대한 수요 증가, 생물제제 및 바이오시밀러 전달 솔루션 확대, 환자 중심 약물 투여에 대한 집중 강화 등이 있습니다.
만성질환 증가가 예상에 따라 첨단 약물전달시스템 시장의 확대가 촉진될 것으로 예측됩니다. 1년 이상 지속되고 지속적인 치료가 필요한 만성질환은 흡연, 간접흡연, 영양부족, 운동부족, 과도한 음주 등 다양한 위험행동에 기인합니다. 첨단 약물전달 시스템은 만성질환의 영향을 받는 특정 부위에 치료제를 정확하게 전달하여 약효를 높이고 부작용을 최소화하는 데 중요한 역할을 합니다. 예를 들어 유엔(UN)의 2023년 5월 기준 자료에 따르면 미국내 사망 원인 10건 중 7건이 만성질환으로 인한 사망으로 연간 170만 명 이상이 목숨을 잃고 있습니다. 따라서 만성질환의 유병률 증가는 첨단 약물전달 시스템 시장의 성장을 지원하는 기반이 되고 있습니다.
첨단 약물전달 시스템의 주요 기업은 복잡한 치료제를 편리하고 신속하며 환자 중심의 방식으로 투여해야 한다는 요구에 부응하기 위해 피하 생물제제 전달 기술을 포함한 혁신적인 접근법 개발을 우선순위에 두고 있습니다. 피하 생물제제 전달 기술은 피부 아래에 다량의 약물을 투여할 수 있으며, 기존 정맥주사 대비 덜 침습적인 선택지를 제공합니다. 예를 들어 2023년 6월 Halozyme Therapeutics는 범발성 중증 근무력증 적응증을 가진 새로운 피하 제제 'VYVGART Hytrulo with ENHANZE'에 대해 미국 식품의약국(FDA)의 승인을 획득했다고 발표했습니다. 이 제품은 에프가루티기모도알파와 Halozyme사의 재조합 인간 히알루로니다제 PH20(rHuPH20)을 결합하여 1회 주사로 빠르고 고용량의 피하 투여가 가능합니다. 이 방법으로 투약 시간이 몇 초로 단축되어 환자의 편의성이 향상되었습니다. 병원 외의 환경에서도 치료가 가능하며, 정맥투여와 동등한 임상적 효과를 유지합니다.
목차
제1장 개요
제2장 시장의 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 용도 산업의 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장의 세계 TAM(Total Addressable Market)
제9장 시장 세분화
제10장 지역별·국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 대기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 합병과 인수
제40장 시장의 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSA
영문 목차
영문목차
Advanced drug delivery systems refer to innovative techniques and formulations designed to enhance the targeted distribution, bioavailability, and efficacy of pharmaceutical medications. These systems aim to maximize drug efficacy while minimizing side effects, providing controlled drug release rates, and targeting specific areas of the body.
The main types of advanced drug delivery systems include oral drug delivery systems, injection-based drug delivery systems, inhalation or pulmonary drug delivery systems, transdermal drug delivery systems, transmucosal drug delivery systems, carrier-based drug delivery systems, and others. The oral drug delivery system involves introducing a chemical through the mouth or into the gastrointestinal tract for systemic activity. Carrier types in these systems include liposomes, nanoparticles, microspheres, monoclonal antibodies, and others. Various technologies, such as prodrugs, implants, intrauterine devices, targeted drug delivery, polymeric drug delivery, and others, are employed. These delivery systems find applications in indications such as cardiovascular diseases, oncology, urology, diabetes, central nervous system (CNS) disorders, ophthalmology, inflammatory diseases, infections, and more. They are utilized by hospitals, specialized clinics, and clinical research and development centers.
Tariffs are impacting the advanced drug delivery systems market by increasing costs of imported polymers, nanoparticles, specialty excipients, delivery devices, and precision manufacturing equipment. Pharmaceutical manufacturers in North America and Europe are most affected due to globalized raw material sourcing, while Asia-Pacific faces higher costs in exporting advanced formulations. These tariffs are increasing development and production expenses. However, they are also encouraging regional sourcing of materials, localized manufacturing, and innovation in cost-optimized drug delivery technologies.
The advanced drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides advanced drug delivery systems market statistics, including advanced drug delivery systems industry global market size, regional shares, competitors with a advanced drug delivery systems market share, detailed advanced drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the advanced drug delivery systems industry. This advanced drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The advanced drug delivery systems market size has grown strongly in recent years. It will grow from $285.59 billion in 2025 to $310.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to expansion of pharmaceutical R&D activities, rising prevalence of chronic diseases, advancements in formulation science, growth of injectable drug therapies, increased focus on treatment efficacy.
The advanced drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $433.56 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising adoption of biologics, expansion of nanotechnology-based therapies, growing focus on reducing drug side effects, increasing investments in advanced pharmaceutical delivery platforms. Major trends in the forecast period include increasing adoption of targeted drug delivery technologies, rising use of nanocarrier-based formulations, growing demand for controlled release systems, expansion of biologic and biosimilar delivery solutions, enhanced focus on patient-centric drug administration.
The anticipated rise in chronic conditions is poised to drive the expansion of the advanced drug delivery systems market. Chronic conditions, persisting for a year or longer and necessitating ongoing medical care, are attributed to various risk behaviors such as tobacco use, exposure to secondhand smoke, poor nutrition, physical inactivity, and excessive alcohol use. Advanced drug delivery systems play a crucial role in precisely delivering therapeutic agents to specific sites affected by chronic conditions, enhancing drug effectiveness, and minimizing side effects. For example, as per May 2023 data from The United Nations (UN), chronic diseases account for seven out of 10 deaths in the US, causing over 1.7 million fatalities annually. Consequently, the increasing prevalence of chronic conditions underpins the growth of the advanced drug delivery systems market.
Leading players in the advanced drug delivery system landscape are prioritizing the development of innovative approaches, including subcutaneous biologic delivery technologies, to address the growing need for convenient, fast, and patient-centric administration of complex therapies. Subcutaneous biologic delivery allows high volumes of medication to be administered beneath the skin, providing a less invasive option compared with conventional intravenous infusions. For example, in June 2023, Halozyme Therapeutics, Inc. announced approval by the United States Food and Drug Administration for VYVGART Hytrulo with ENHANZE, a novel subcutaneous formulation indicated for generalized myasthenia gravis. This product combines efgartigimod alfa with Halozyme's recombinant human hyaluronidase PH20 (rHuPH20), enabling rapid, high-volume subcutaneous administration through a single injection. The approach shortens administration time to seconds, enhances patient convenience, enables treatment beyond hospital settings, and preserves clinical effectiveness comparable to intravenous delivery.
In November 2023, Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on therapies for Alzheimer's disease, entered into a collaboration with Halozyme Therapeutics, Inc. to develop a subcutaneous formulation of ACU193 utilizing ENHANZE technology. Through this collaboration, the companies seek to enhance patient-focused drug delivery by enabling a more convenient and efficient subcutaneous administration of ACU193 while maintaining therapeutic performance. Halozyme Therapeutics, Inc. provides specialized drug delivery solutions, including ENHANZE technology, which supports subcutaneous delivery of biologics and helps reduce the overall treatment burden for patient
Major companies operating in the advanced drug delivery systems market are Pfizer Inc., Johnson and Johnson Services Inc., Roche Holding AG, Abbvie Inc., Bayer AG, Novartis AG, AstraZeneca plc, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Astellas Pharma Inc., Catalent Inc., Nipro Corporation, AptarGroup Inc., West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation
North America was the largest region in the advanced drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the advanced drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The advanced drug delivery systems market consists of revenues earned by entities by providing stimuli-responsive drug delivery systems, sustained drug delivery systems, targeted drug delivery systems, and nanoparticle-based drug delivery systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The advanced drug delivery systems market also consists of sales of fentanyl transdermal patches, albuterol inhalers, and hydrogels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Advanced Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses advanced drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for advanced drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The advanced drug delivery systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation Or Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System; Other Types
2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Other Carrier Types
3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
4) By Application: Cardiovascular Diseases; Oncology; Urology; Diabetes; CNS (Central Nervous System); Ophthalmology; Inflammatory Diseases; Infections; Other Applications
5) By End User: Hospitals; Specialized clinics; Clinical Research And Development Centers
Subsegments:
1) By Oral Drug Delivery System: Solid Dosage Forms; Liquid Dosage Forms; Novel Oral Delivery Systems
2) By Injection-Based Drug Delivery System: Autoinjectors; Microneedle-Based Systems
3) By Inhalation Or Pulmonary Drug Delivery System: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs); Nebulizers; Soft Mist Inhalers
4) By Transdermal Drug Delivery System: Transdermal Patches; Microneedle Patches; Iontophoresis Systems
5) By Transmucosal Drug Delivery System: Buccal Delivery Systems; Sublingual Delivery Systems; Nasal Delivery Systems
6) By Carrier-Based Drug Delivery System: Liposomes; Nanoparticles; Dendrimers; Niosomes
7) By Other Types: Implantable Drug Delivery Systems; Targeted Delivery Systems; Bioadhesive Drug Delivery Systems
Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; Roche Holding AG; Abbvie Inc.; Bayer AG; Novartis AG; AstraZeneca plc; GlaxoSmithKline plc; 3M Company; Medtronic plc; Eli Lilly and Company; Boehringer Ingelheim GmbH; Amgen Inc.; Merck Group; Becton Dickinson and Company; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Sanofi S.A.; Boston Scientific Corporation; Astellas Pharma Inc.; Catalent Inc.; Nipro Corporation; AptarGroup Inc.; West Pharmaceutical Services Inc.; Gerresheimer AG; Insulet Corporation
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.2.1 Increasing Adoption Of Targeted Drug Delivery Technologies
4.2.2 Rising Use Of Nanocarrier-Based Formulations
4.2.3 Growing Demand For Controlled Release Systems
4.2.4 Expansion Of Biologic And Biosimilar Delivery Solutions
4.2.5 Enhanced Focus On Patient-Centric Drug Administration
5. Advanced Drug Delivery Systems Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Specialized Clinics
5.3 Clinical Research Centers
5.4 Pharmaceutical Companies
5.5 Biotechnology Firms
6. Advanced Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Advanced Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Advanced Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Advanced Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
7.3. Global Advanced Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Advanced Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Advanced Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Advanced Drug Delivery Systems Market Segmentation
9.1. Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation Or Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Transmucosal Drug Delivery System, Carrier-Based Drug Delivery System, Other Types
9.2. Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Liposomes, Nanoparticles, Microspheres, Other Carrier Types
9.3. Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Other Technologies
9.4. Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.5. Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Specialized clinics, Clinical Research And Development Centers
9.6. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Oral Drug Delivery System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Solid Dosage Forms, Liquid Dosage Forms, Novel Oral Delivery Systems
9.7. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Injection-Based Drug Delivery System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Autoinjectors, Microneedle-Based Systems
9.8. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Inhalation Or Pulmonary Drug Delivery System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.9. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transdermal Drug Delivery System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Transdermal Patches, Microneedle Patches, Iontophoresis Systems
9.10. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Transmucosal Drug Delivery System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Buccal Delivery Systems, Sublingual Delivery Systems, Nasal Delivery Systems
9.11. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Carrier-Based Drug Delivery System, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Liposomes, Nanoparticles, Dendrimers, Niosomes
9.12. Global Advanced Drug Delivery Systems Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Implantable Drug Delivery Systems, Targeted Delivery Systems, Bioadhesive Drug Delivery Systems
10. Advanced Drug Delivery Systems Market Regional And Country Analysis
10.1. Global Advanced Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Advanced Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Advanced Drug Delivery Systems Market
11.1. Asia-Pacific Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Advanced Drug Delivery Systems Market
12.1. China Advanced Drug Delivery Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Advanced Drug Delivery Systems Market
13.1. India Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Advanced Drug Delivery Systems Market
14.1. Japan Advanced Drug Delivery Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Advanced Drug Delivery Systems Market
15.1. Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Advanced Drug Delivery Systems Market
16.1. Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Advanced Drug Delivery Systems Market
17.1. South Korea Advanced Drug Delivery Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Advanced Drug Delivery Systems Market
18.1. Taiwan Advanced Drug Delivery Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Advanced Drug Delivery Systems Market
19.1. South East Asia Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Advanced Drug Delivery Systems Market
20.1. Western Europe Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Advanced Drug Delivery Systems Market
21.1. UK Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Advanced Drug Delivery Systems Market
22.1. Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Advanced Drug Delivery Systems Market
23.1. France Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Advanced Drug Delivery Systems Market
24.1. Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Advanced Drug Delivery Systems Market
25.1. Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Advanced Drug Delivery Systems Market
26.1. Eastern Europe Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Advanced Drug Delivery Systems Market
27.1. Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Advanced Drug Delivery Systems Market
28.1. North America Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Advanced Drug Delivery Systems Market
29.1. USA Advanced Drug Delivery Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Advanced Drug Delivery Systems Market
30.1. Canada Advanced Drug Delivery Systems Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Advanced Drug Delivery Systems Market
31.1. South America Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Advanced Drug Delivery Systems Market
32.1. Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Advanced Drug Delivery Systems Market
33.1. Middle East Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Advanced Drug Delivery Systems Market
34.1. Africa Advanced Drug Delivery Systems Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Segmentation By Carrier Type, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Advanced Drug Delivery Systems Market Regulatory and Investment Landscape
36. Advanced Drug Delivery Systems Market Competitive Landscape And Company Profiles
36.1. Advanced Drug Delivery Systems Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Advanced Drug Delivery Systems Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Advanced Drug Delivery Systems Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Johnson and Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Abbvie Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
37. Advanced Drug Delivery Systems Market Other Major And Innovative Companies
Novartis AG, AstraZeneca plc, GlaxoSmithKline plc, 3M Company, Medtronic plc, Eli Lilly and Company, Boehringer Ingelheim GmbH, Amgen Inc., Merck Group, Becton Dickinson and Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Boston Scientific Corporation, Astellas Pharma Inc.
38. Global Advanced Drug Delivery Systems Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Advanced Drug Delivery Systems Market
40. Advanced Drug Delivery Systems Market High Potential Countries, Segments and Strategies
40.1 Advanced Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
40.2 Advanced Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
40.3 Advanced Drug Delivery Systems Market In 2030 - Growth Strategies
